Conquer Cancer, the ASCO Foundation, has named Josephine Lopes Cardozo, Abdul Rafeh Naqash, Antonio Di Meglio, Amy Yuan Wang, and Alanna Church as Special Merit Award recipients of the 2021 ASCO annual meeting.
Conquer Cancer, the ASCO Foundation, has named the recipients of its 2021 Medical Student Rotation for Underrepresented Populations and Annual Meeting Research Award.
Jazz Pharmaceuticals has established Nothing Small About It, an online program developed with consultation from cancer organizations CancerCare, GO2 Foundation for Lung Cancer, Lung Cancer Foundation of America and LUNGevity Foundation.
The Association of Community Cancer Centershas has launched Cancer Buzz TV, a video podcast channel aimed at informing oncology professionals of the latest developments in cancer care.
The FY21 KCRP Program Announcements and General Application Instructions for Kidney Cancer Care Research Program can be found here.
Thermo Fisher Scientific has opened submissions for the Oncomine Clinical Research Grant program to support clinical research projects in oncology.
The Pancreatic Cancer Action Network has added another treatment arm by biopharmaceutical company FibroGen Inc. to its clinical trial platform, Precision Promise.
Data from three pivotal phase III studies—CLL14, MURANO and VIALE-A—of Venclexta (venetoclax) support the primary analysis of Venclexta in chronic lymphocytic leukemia and the possibility of tailoring treatment approaches based on genetic risk factors.
In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.
Pairing sky-mapping algorithms with advanced immunofluorescence imaging of cancer biopsies, researchers at The Mark Foundation Center for Advanced Genomics and Imaging at Johns Hopkins University and the Bloomberg-Kimmel Institute for Cancer Immunotherapy developed a robust platform to guide immunotherapy by predicting which cancers will respond to specific therapies targeting the immune system.
